Lentivirus infection in the brain induces matrix metalloproteinase expression: Role of envelope diversity

Journal of Virology

Volumn 74, Issue 16, 2000, Pages 7211-7220

  Johnston, J B ^a   Jiang, Y ^a   Van Marle, M ^a   Mayne, W ^a   Ni, W ^a   Holden, J ^a   McArthur, J C ^a   Power, C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GELATINASE A; GELATINASE B; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME INDUCTION; FELINE IMMUNODEFICIENCY VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

AIDS DEMENTIA COMPLEX; ANIMALS; BRAIN; CATS; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, ENV; HIV; HIV INFECTIONS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS; LENTIVIRUS INFECTIONS; MACROPHAGES; MATRIX METALLOPROTEINASES; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 0033852422     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.16.7211-7220.2000     Document Type: Article

References (77)

1. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes
2. The AP-1 site and MMP gene regulation: What is all the fuss about?
3. Microglial activation and neurological symptoms in the SIV model of neuroAIDS: Association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes
4. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
5. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection
6. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection
7. Vascular changes in the cerebral cortex in HIV-1 infection. II. An immunohistochemical and lectinhistochemical investigation
8. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin
9. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia
10. Chemokine modulation of matrix metalloproteinase and TIMP production in adult rat brain microglia and a human microglial cell line in vitro
11. HIV infection of macrophages and pathogenesis of AIDS dementia complex: Interaction of the host cell and viral genotype
12. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
13. Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells
14. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: Expression and replication in macrophages
15. Human immunodeficiency virus type i infection of the nervous system: Pathogenetic mechanisms
16. Fludarabine-induced immuno-suppression is associated with inhibition of STAT1 signaling
17. Neuropathologic aspects of lentiviral infections
18. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes
19. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
20. Matrix metalloproteinases in immunity
21. Neurotoxic effects of feline immunodeficiency virus, FIV-PPR
22. Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system
23. Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development
24. Differences among HIV-1 variants in their ability to elicit secretion of TNF-alpha
25. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
26. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures
27. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
28. Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: Insights into the pathogenesis of AIDS dementia complex
29. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex
30. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB
31. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages
32. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists
33. Pathogenesis of simian immunodeficiency virus encephalitis: Viral determinants of neurovirulence
34. Induction of matrix metalloproteinase-2 in human immunodeficiency virus-1 glycoprotein 120 transgenic mouse brains
35. Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients
36. Neurologic manifestations of AIDS. Medicine (Baltimore)
37. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease
38. Chemokines regulate hippocampal-neuronal signaling and gp120 neurotoxicity
39. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
40. Activation mechanisms of matrix metalloproteinases
41. Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells
42. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes
43. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB
44. HIV decreases glutamate transport in SK-N-MC neuroblastoma cells
45. Retrovirus-induced murine motor neuron disease: Mapping the determinant of spongiform degeneration within the envelope gene
46. Central nervous system involvement in human immunodeficiency virus disease. A prospective study including neurological examination, computerized tomography, and magnetic resonance imaging
47. HIV-1 infection induces a selective reduction in STAT5 protein expression
48. Mechanism of monocyte-macrophage-mediated transmission of HIV
49. Neurological abnormalities associated with feline immunodeficiency virus infection
50. Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus
51. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway
52. Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression
53. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier
54. Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence
55. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences
56. Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients
57. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia
58. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: Implications for chemotaxis
59. Matrix metalloproteinases in brain injury
60. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis
61. 2+-based reverse transcriptase assay for detection of primate retroviruses
62. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways
63. Presence of matrix metalloproteinase-9 activity in the cerebro-spinal fluid of human immunodeficiency virus-infected patients
64. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
65. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: Evidence of differential tropism
66. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9
67. A Val-25-to-Ile substitution in the envelope precursor polyprotein, gPr80env, is responsible for the temperature sensitivity, inefficient processing of gPr80env, and neurovirulence of ts1, a mutant of Moloney murine leukemia virus TB
68. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins
69. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway
70. Animal models recapitulate aspects of HIV/CNS disease
71. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia
72. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses
73. RANTES and MIP-1alpha activate stats in T cells
74. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1
75. Matrix metalloproteinases and diseases of the CNS
76. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: Implications for human immunodeficiency virus type 1-associated dementia
77. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia